Second generation drugs-derivatives of natural antitumor anthracycline antibiotics daunorubicin, doxorubicin and carminomycin

Maria N. Preobrazhenskaya, Anna N. Tevyashova, Eugenia N. Olsufyeva, Kuo Feng Huang, Hsu Shan Huang

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

Anthracycline antibiotics are among the most effective chemotherapy agents currently in use for cancer treatment; however irreversible cardiac damage is a major dose-limiting toxicity, restricting life-time cumulative dose. Besides, the therapeutic activity of many drugs of this class is low if tumor cells express multidrug resistance mediated by a decreased drug accumulation. With the aim of decreasing toxic side effects and also of finding drugs effective in treatment tumors resistant to existing antitumor drugs, investigations are being carried out widely on the synthesis of different analogues of anthracycline antibiotics and the methods of tumor targeted delivery. The design of new generation potential anticancer agents based on known structural principles was found to produce compounds with significantly increased chemotherapeutical indexes.

Original languageEnglish
Pages (from-to)119-128
Number of pages10
JournalJournal of Medical Sciences (Taiwan)
Volume26
Issue number4
Publication statusPublished - Aug 2006
Externally publishedYes

Fingerprint

Carubicin
Daunorubicin
Anthracyclines
Doxorubicin
Anti-Bacterial Agents
Pharmaceutical Preparations
Antineoplastic Agents
Neoplasms
Poisons
Multiple Drug Resistance
Therapeutics
Drug Therapy

Keywords

  • Anthracycline antibiotics
  • Anticancer chemotherapy
  • Carminomycin
  • Chemical modification
  • Daunorubicin
  • Doxorubicin
  • Multidrug resistance (MDR)

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Second generation drugs-derivatives of natural antitumor anthracycline antibiotics daunorubicin, doxorubicin and carminomycin. / Preobrazhenskaya, Maria N.; Tevyashova, Anna N.; Olsufyeva, Eugenia N.; Huang, Kuo Feng; Huang, Hsu Shan.

In: Journal of Medical Sciences (Taiwan), Vol. 26, No. 4, 08.2006, p. 119-128.

Research output: Contribution to journalArticle

Preobrazhenskaya, Maria N. ; Tevyashova, Anna N. ; Olsufyeva, Eugenia N. ; Huang, Kuo Feng ; Huang, Hsu Shan. / Second generation drugs-derivatives of natural antitumor anthracycline antibiotics daunorubicin, doxorubicin and carminomycin. In: Journal of Medical Sciences (Taiwan). 2006 ; Vol. 26, No. 4. pp. 119-128.
@article{ecfb511a22bb481997560c5166afc43f,
title = "Second generation drugs-derivatives of natural antitumor anthracycline antibiotics daunorubicin, doxorubicin and carminomycin",
abstract = "Anthracycline antibiotics are among the most effective chemotherapy agents currently in use for cancer treatment; however irreversible cardiac damage is a major dose-limiting toxicity, restricting life-time cumulative dose. Besides, the therapeutic activity of many drugs of this class is low if tumor cells express multidrug resistance mediated by a decreased drug accumulation. With the aim of decreasing toxic side effects and also of finding drugs effective in treatment tumors resistant to existing antitumor drugs, investigations are being carried out widely on the synthesis of different analogues of anthracycline antibiotics and the methods of tumor targeted delivery. The design of new generation potential anticancer agents based on known structural principles was found to produce compounds with significantly increased chemotherapeutical indexes.",
keywords = "Anthracycline antibiotics, Anticancer chemotherapy, Carminomycin, Chemical modification, Daunorubicin, Doxorubicin, Multidrug resistance (MDR)",
author = "Preobrazhenskaya, {Maria N.} and Tevyashova, {Anna N.} and Olsufyeva, {Eugenia N.} and Huang, {Kuo Feng} and Huang, {Hsu Shan}",
year = "2006",
month = "8",
language = "English",
volume = "26",
pages = "119--128",
journal = "Journal of Medical Sciences",
issn = "1011-4564",
publisher = "國防醫學院",
number = "4",

}

TY - JOUR

T1 - Second generation drugs-derivatives of natural antitumor anthracycline antibiotics daunorubicin, doxorubicin and carminomycin

AU - Preobrazhenskaya, Maria N.

AU - Tevyashova, Anna N.

AU - Olsufyeva, Eugenia N.

AU - Huang, Kuo Feng

AU - Huang, Hsu Shan

PY - 2006/8

Y1 - 2006/8

N2 - Anthracycline antibiotics are among the most effective chemotherapy agents currently in use for cancer treatment; however irreversible cardiac damage is a major dose-limiting toxicity, restricting life-time cumulative dose. Besides, the therapeutic activity of many drugs of this class is low if tumor cells express multidrug resistance mediated by a decreased drug accumulation. With the aim of decreasing toxic side effects and also of finding drugs effective in treatment tumors resistant to existing antitumor drugs, investigations are being carried out widely on the synthesis of different analogues of anthracycline antibiotics and the methods of tumor targeted delivery. The design of new generation potential anticancer agents based on known structural principles was found to produce compounds with significantly increased chemotherapeutical indexes.

AB - Anthracycline antibiotics are among the most effective chemotherapy agents currently in use for cancer treatment; however irreversible cardiac damage is a major dose-limiting toxicity, restricting life-time cumulative dose. Besides, the therapeutic activity of many drugs of this class is low if tumor cells express multidrug resistance mediated by a decreased drug accumulation. With the aim of decreasing toxic side effects and also of finding drugs effective in treatment tumors resistant to existing antitumor drugs, investigations are being carried out widely on the synthesis of different analogues of anthracycline antibiotics and the methods of tumor targeted delivery. The design of new generation potential anticancer agents based on known structural principles was found to produce compounds with significantly increased chemotherapeutical indexes.

KW - Anthracycline antibiotics

KW - Anticancer chemotherapy

KW - Carminomycin

KW - Chemical modification

KW - Daunorubicin

KW - Doxorubicin

KW - Multidrug resistance (MDR)

UR - http://www.scopus.com/inward/record.url?scp=33748536098&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33748536098&partnerID=8YFLogxK

M3 - Article

VL - 26

SP - 119

EP - 128

JO - Journal of Medical Sciences

JF - Journal of Medical Sciences

SN - 1011-4564

IS - 4

ER -